Overall, our VHL-deficient simulations indicate that a combination of VHL loss and cell cycle-promoting oncogene activation is required for cancer progression, breaking Hif-1⍺ and/or EMT-induced cell cycle arrest. The gene discussed is HIF1A; the disease is cancer.